Publication | Closed Access

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Placebo-controlled Freedoms StudyDisease ProgressionNeurological DisorderDisabilityClinical TrialsDisability OutcomesOutcomes ResearchRehabilitationNeurologyMultiple SclerosisNeurorehabilitationMedicine